Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Pr-924 | 1416709-79-9 | 98.9% | 618.72 | C37H38N4O5 | 25MG
Supplier: Medchemexpress LLC HY12358725MG
PR-924 is a selective tripeptide epoxyketone inhibitor targeting the immunoproteasome subunit LMP-7. It covalently modifies proteasomal N-terminal threonine active sites, exhibits low-nanomolar potency (IC50 ≈ 22 nM), and has demonstrated antiproliferative and pro-apoptotic activity in multiple myeloma models. Intended for research use only.
- Selective LMP-7 inhibition with low-nanomolar potency (IC50 ≈ 22 nM).
- Covalent, irreversible mechanism of action for target engagement.
- Demonstrated antiproliferative and pro-apoptotic activity in preclinical models.
- High purity to support reproducible experimental results.
- Available in multiple solid and solution formats for flexible dosing.
- Supplied for research use only; not for human use.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?